<DOC>
	<DOC>NCT02180737</DOC>
	<brief_summary>Evaluation of the role of dexmedetomidine as a sole agent in sedating patients undergoing interventional radiological procedures and measuring its different outcome variables.</brief_summary>
	<brief_title>Dexmedetomidine for Sedation During Radiological Interventional Procedures</brief_title>
	<detailed_description />
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Age from 1865 years old ASA physical status of III Expected procedure lasting at least 30 minutes Unstable cardiac status (lifethreatening arrhythmias, abnormal cardiac anatomy, significant cardiac dysfunction and thirddegree heart block. An alpha2agonist or antagonist within 14 days before the scheduled procedure. patients received an IV opioid within 1 h, or an oral or IM opioid within 4 h of the start of study drug administration. Patients who are allergic to Dexmedetomidine or alpha 2agonists.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>dexmedetomedine</keyword>
	<keyword>sedation</keyword>
	<keyword>interventional radiology</keyword>
</DOC>